BlossomHill Therapeutics Statistics
NASDAQ: BLSMHealth CareBiotechnology: Pharmaceutical PreparationsUSD
14.51+0.10 (+0.69%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
BlossomHill Therapeutics by the numbers
BlossomHill Therapeutics has a market capitalization of $461.2 million based on 31.78M shares outstanding. With trailing EPS of $-10.38, BlossomHill Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 16.0% below its 50-day average and 17.5% below its 200-day average.
Average daily trading volume is 193.15K shares, or about $2.8 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
BLSM valuation vs. peer median
| Metric | BLSM | Peer median | Difference |
|---|---|---|---|
| Market cap | $461.20M | $459.66M | +0% |
| Avg. volume | 193.15K | 244.41K | -21% |
Peer median across 8 companies: NGNE, GYRE, ASMB, STTK, RZLT, MNPR, EVO, KMDA.
Valuation
- Market cap
- $461.20M
- EPS (TTM)
- $-10.38
- Shares outstanding
- 31.78M
Price and trading
- Previous close
- 14.41
- Open
- 14.34
- Day range
- 13.90 – 15.63
- 52-week range
- 11.02 – 27.99
- Beta
- —
- Volume
- 270.74K
- Average volume
- 193.15K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 12, 2026
Additional statistics
- Market Cap
- 461.20M
- Forward Pe
- -3.62
- Eps
- -10.38
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 27.99
- Week52 Low
- 11.02
- Avg Volume
- 193.15K
- Shares Outstanding
- 31.78M
- Ma50
- 17.27
- Ma200
- 17.60
- Earnings Date
- Nov 12, 2026
- Pct From52w High
- -48.16%
- Pct From52w Low
- 31.67%